Polaris Venture Management Co. V

Latest statistics and disclosures from Polaris Venture Management Co. V's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are LYRA, XFOR, Atyr Pharma Inc Common Stock Usd 0.001, DARE, GNCA, and represent 97.96% of Polaris Venture Management Co. V's stock portfolio.
  • Reduced shares in these 1 stocks: FATE (-$50M).
  • Sold out of its positions in FATE.
  • Polaris Venture Management Co. V was a net seller of stock by $-50M.
  • Polaris Venture Management Co. V has $14M in assets under management (AUM), dropping by -77.43%.
  • Central Index Key (CIK): 0001439589

Tip: Access up to 7 years of quarterly data

Positions held by Polaris Venture Management Co. V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Polaris Venture Management Co. V

Companies in the Polaris Venture Management Co. V portfolio as of the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Lyra Therapeutics Common Stock (LYRA) 71.3 $10M 1.1M 9.12
x4 Pharmaceuticals Common Stock (XFOR) 11.7 $1.6M 312k 5.29
Atyr Pharma Common Stock 8.4 $1.2M 131k 9.08
Dare Bioscience Common Stock (DARE) 3.9 $545k 326k 1.67
Genocea Biosciences Common Stock (GNCA) 2.7 $379k 197k 1.92
Pulmatrix Common Stock (PULM) 2.0 $288k 359k 0.80

Past Filings by Polaris Venture Management Co. V

SEC 13F filings are viewable for Polaris Venture Management Co. V going back to 2014

View all past filings